On-demand versus continuous proton pump inhibitor therapy as first-line treatment for gastroesophageal reflux disease: a single-center prospective study

(1) University of Ulsan College of Medicine, Asan Medical Center,Seoul,Korea (Republic of)



This item was part of the Oesophageal, Gastric and Duodenal Disorders II (Posters) session at UEG Week 2019

This item can be cited as: United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019